Nephrogenic systemic fibrosis

A scleromyxedema-like disease was recognized in 1997. In 2000 this disorder was first published and termed nephrogenic fibrosing dermopathy because all patients had advanced renal failure. In 2006 it was discovered that the patients had a history of a preceding contrast-enhanced magnetic resonance i...

Full description

Saved in:
Bibliographic Details
Published in:Radiologe 2007-09, Vol.47 (9), p.778
Main Author: Samtleben, W
Format: Article
Language:ger
Subjects:
Contrast Media - adverse effects
Disease Progression
Fibrosis - chemically induced
Fibrosis - pathology
Gadolinium DTPA - adverse effects
Glomerular Filtration Rate
Humans
Kidney Transplantation
Magnetic Resonance Imaging - adverse effects
Male
Middle Aged
Renal Dialysis
Renal Insufficiency - complications
Renal Insufficiency - therapy
Risk Factors
Scleromyxedema - chemically induced
Skin - pathology
Skin Diseases - chemically induced
Skin Diseases - pathology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A scleromyxedema-like disease was recognized in 1997. In 2000 this disorder was first published and termed nephrogenic fibrosing dermopathy because all patients had advanced renal failure. In 2006 it was discovered that the patients had a history of a preceding contrast-enhanced magnetic resonance imaging (MRI). All patients had acute or chronic severe renal insufficiency with a glomerular filtration rate (GFR)
ISSN:0033-832X
DOI:10.1007/s00117-007-1545-1